Simon V. Arnett
Southport, QLD 4215, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Treatment outcomes in multiple sclerosis using reduced and extended interval ocrelizumab dosing.
Journal: Multiple sclerosis and related disorders
Published: March 09, 2025
Aquaporin-4 Immunoglobulin G-seropositive Neuromyelitis Optica Spectrum Disorder MRI Characteristics: Data Analysis from the International Real-World PAMRINO Study Cohort.
Journal: Radiology
Published: November 12, 2024
Sex ratio and age of onset in AQP4 antibody-associated NMOSD: a review and meta-analysis.
Journal: Journal of neurology
Published: March 14, 2024
Long-term outcomes of ADEM-like and tumefactive presentations of CNS demyelination: a case-comparison analysis.
Journal: Journal of neurology
Published: December 09, 2023
Response to treatment in NMOSD: the Australasian experience.
Journal: Multiple sclerosis and related disorders
Published: September 30, 2021
Low vitamin D levels do not predict risk of autoimmune disease following alemtuzumab treatment for multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: July 14, 2021
Magnetic resonance imaging in neuromyelitis optica spectrum disorder.
Journal: Clinical and experimental immunology
Published: March 08, 2021
Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation.
Journal: Frontiers in neurology
Published: March 12, 2020
The clinical profile of NMOSD in Australia and New Zealand.
Journal: Journal of neurology
Published: November 05, 2019
Inflammatory fatigue and sickness behaviour - lessons for the diagnosis and management of chronic fatigue syndrome.
Journal: Journal of affective disorders
Published: October 06, 2011
Chronic fatigue syndrome--a neuroimmunological model.
Journal: Medical hypotheses
Published: October 22, 2010
Showing 1-12 of 12
Last Updated: 09/26/2026